home / openregs / documents

documents: FDA-2026-P-1833-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-1833-0004 FDA FDA-2026-P-1833 Attachment 2 - Current Electronic Edition of the Approved Drug Products with Therapeutic Equivalence Evaluations - Tolmetin Sodium Supporting & Related Material Background Material 2026-02-19T05:00:00Z 2026 2     2026-02-20T00:31:03Z   0 0 09000064b91bf195

Links from other tables

  • 0 rows from regs_document_id in fr_regs_crossref
Powered by Datasette · Queries took 52.912ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API